Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R. Mutell
PUK15 a Managed Care Cost-Offset Model for Ferric Citrate, an Experimental Phosphate Binder That Can Reduce the Use of Erythropoiesis-Stimulating Agents and Intravenous Iron in Hemodialysis Patients With Hyperphosphatemia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD
Journal of the American Society of Nephrology : JASN
Medicine
Nephrology
Intravenous Iron and Erythropoiesis-Stimulating Agents in Haemodialysis: A Systematic Review and Meta-Analysis
Nephrology
Medicine
Nephrology
Intravenous Iron Versus Oral Iron Versus No Iron With or Without Erythropoiesis- Stimulating Agents (ESA) for Cancer Patients With Anaemia: A Systematic Review and Network Meta-Analysis
Cochrane Database of Systematic Reviews
The Phosphate Binder Ferric Citrate Alters the Gut Microbiome in Rats With Chronic Kidney Disease
Journal of Pharmacology and Experimental Therapeutics
Molecular Medicine
Pharmacology
Randomized Clinical Trial of the Iron-Based Phosphate Binder PA21 in Hemodialysis Patients
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
Ferric Citrate Hydrate for the Treatment of Hyperphosphatemia in Nondialysis-Dependent CKD
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine
Potentially Modifiable Factors Associated With Non-Adherence to Phosphate Binder Use in Patients on Hemodialysis
BMC Nephrology
Nephrology
PCN34 Cost Analysis of Anemia Treatment With Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
DGI-043 Increased Cost of Erythropoiesis-Stimulating Agents in Some Special Situations
European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
